Navigating Biotech's Valuation Maze & Dilution Headwinds?
Is the current climate of valuation pressures and down rounds impacting your biotech investments? Protecting your existing stakes while still fostering growth in promising assets is a critical challenge.
Dare Bioventures offers a unique solution. We invest directly in high-potential drug assets through dedicated subsidiaries, providing non-dilutive capital that advances development without impacting the parent company's cap table or valuation.
Discover how to fuel biotech innovation and preserve equity.